<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7278987\results\search\drug\results.xml">
  <result pre="with similar activities, either as monotherapy or in association with" exact="mycophenolic acid," post="been shown against the MERS-CoV PLP [77]. Due to"/>
  <result pre="would like to highlight that a recent report demonstrated that" exact="disulfiram" post="(a clinically approved alcohol abuse antagonist, now repurposed as"/>
  <result pre="that a recent report demonstrated that disulfiram (a clinically approved" exact="alcohol" post="abuse antagonist, now repurposed as an anticancer drug) can"/>
  <result pre="and MERS PLPs, respectively, and this activity is synergic with" exact="6-thioguanine" post="(a thiopurine) and mycophenolic acid against MERS, but not"/>
  <result pre="and this activity is synergic with 6-thioguanine (a thiopurine) and" exact="mycophenolic acid" post="against MERS, but not SARS, PLP [78]. These recent"/>
  <result pre="vitro, together with a relatively good risk/benefit ratio, may make" exact="disulfiram" post="a clinically evaluable drug against COVID-19. However, as a"/>
  <result pre="may need to be retrospective and their administration reasoned cautiously." exact="Disulfiram" post="may be tested more safely, paying attention to its"/>
  <result pre="more safely, paying attention to its pharmacological interactions and any" exact="alcohol" post="consumption. Author Contributions V.C., P.D. and M.B. wrote the"/>
  <result pre="Trends202014697110.5582/bst.2020.0102031996494 10.CortegianiA.IngogliaG.IppolitoM.GiarratanoA.EinavS.A systematic review on the efficacy and safety of" exact="chloroquine" post="for the treatment of COVID-19J. Crit. Care202010.1016/j.jcrc.2020.03.005 11.ChenC.ZhangX.R.JuZ.Y.HeW.F.[Advances in"/>
  <result pre="Sci. USA2016113E5192E520110.1073/pnas.160343511327519799 52.LiS.-W.LaiC.-C.PingJ.-F.TsaiF.-J.WanL.LinY.-J.KungS.-H.LinC.-W.Severe acute respiratory syndrome coronavirus papain-like protease suppressed" exact="alpha" post="interferon-induced responses through downregulation of extracellular signal-regulated kinase 1-mediated"/>
  <result pre="of severe acute respiratory syndrome coronavirusBiochem. Pharmacol.2008751601160910.1016/j.bcp.2008.01.00518313035 77.ChengK.-W.ChengS.-C.ChenW.-Y.LinM.-H.ChuangS.-J.ChengI.-H.SunC.-Y.ChouC.-Y.Thiopurine analogs and" exact="mycophenolic acid" post="synergistically inhibit the papain-like protease of Middle East respiratory"/>
  <result pre="The facts during the third epidemicLiver Transpl.202010.1002/lt.2575632196933 94.LiH.S.KuokD.I.T.CheungM.C.NgM.M.T.NgK.C.HuiK.P.Y.PeirisJ.S.M.ChanM.C.W.NichollsJ.M.Effect of interferon" exact="alpha" post="and cyclosporine treatment separately and in combination on Middle"/>
  <result pre="during the third epidemicLiver Transpl.202010.1002/lt.2575632196933 94.LiH.S.KuokD.I.T.CheungM.C.NgM.M.T.NgK.C.HuiK.P.Y.PeirisJ.S.M.ChanM.C.W.NichollsJ.M.Effect of interferon alpha and" exact="cyclosporine" post="treatment separately and in combination on Middle East Respiratory"/>
  <result pre="95.MehtaP.McAuleyD.F.BrownM.SanchezE.TattersallR.S.MansonJ.J.COVID-19: Consider cytokine storm syndromes and immunosuppressionLancet20203951033103410.1016/S0140-6736(20)30628-032192578 96.YannakiE.PapadopoulouA.AthanasiouE.KaloyannidisP.ParaskevaA.BougiouklisD.PalladasP.YiangouM.AnagnostopoulosA.The proteasome inhibitor" exact="bortezomib" post="drastically affects inflammation and bone disease in adjuvant-induced arthritis"/>
  <result pre="PLP protease and MERS-CoV PLP protease and DUB Clinically used" exact="6-Mercaptopurine" post="Acethaldeyde dehydrogenase inhibitor [78] Disulfiram SARS and MERS-CoV PLPs"/>
  <result pre="protease and DUB Clinically used 6-Mercaptopurine Acethaldeyde dehydrogenase inhibitor [78]" exact="Disulfiram" post="SARS and MERS-CoV PLPs Clinically used Endogenous peptide [79]"/>
 </snippets>
</snippetsTree>
